More News! 19 Sep 2018 Argenx Attracts Huge €250M Investment Following Positive Phase II Trial Belgian biotech Argenx raised over €250M in public investment on the Nasdaq Stock Market after announcing positive Phase II results for its lead autoimmune drug candidate. The company now plans to progress efgartigimod, an antibody fragment inspired by llama antibodies, to Phase III trials for treatment of the autoimmune blood disease primary immune thrombocytopenia (ITP). […] September 19, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 19 Sep 2018 This Liver Model Made With 4D Bioprinting Could Improve Drug Toxicity Testing Poietis has partnered with the pharma company Servier to develop a 4D bioprinted liver model that could predict liver toxicity of drugs better than current methods. Liver toxicity testing is one of the key tests that are performed during preclinical trials with investigational drugs. “The role of the liver is to degrade substances toxic to […] September 19, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 19 Sep 2018 Using Stem Cells to Save the Northern White Rhino Stem cells are recognized for their therapeutic promise in regenerative medicine, but did you know that they’re also being used to save endangered species? Four hours north of Nairobi, closely safeguarded by armed security, the last remaining northern white rhinoceros are waiting for extinction. Only two animals are left, both of them living in a […] September 19, 2018 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 18 Sep 2018 Cockle Molecules Could Help Fight Cancer As you eat your plate of delicious cockles, spare a thought for how their sugars might help to tackle cancer, suggest researchers from the University of Salford, UK. Testing cockle-derived sugars on cancer cells in the lab, the research group found that they have a similar anti-cancer effect to many regular chemotherapy drugs, but with […] September 18, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 18 Sep 2018 Update: French Biotech Raises €22M for a Gene Therapy Trial in Retinitis Pigmentosa Update (18/09/2018): Horama has increased the total raised in its Series B fundraising to €22.5M, with the Belgian fund V-Bio Ventures joining the team of investors backing the company. The funds will be mainly directed at developing Horama’s gene therapy for retinitis pigmentosa. Published on 08/10/2017 Horama has raised a second fundraising round that will support […] September 18, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 17 Sep 2018 Brewing Pheromones for Pest Control Harmful pesticides on your food may be less of a worry in the future, as a Danish biotech company has received a €3M investment to market a safer and more eco-friendly form of agricultural pest control: pheromones. The company, BioPhero, has developed an innovative yeast fermentation method for cheaply producing these pheromones on an industrial […] September 17, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 17 Sep 2018 The First ‘Genomic Internet’ Has Been Launched The Russian non-profit Zenome.io has launched today the beta release of the first decentralized ‘genomic internet’, which is expected to make possible the safe storage of large amounts of genetic data. Genomics is one of the largest generators of data on the internet, more than Twitter and YouTube according to Zenome. Using a decentralized network […] September 17, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 16 Sep 2018 Meet the Entrepreneurs Doing Biotech from Shipping Containers in London Creative biotech startups are brewing inside a shipping container park that offers affordable research space for biologists, engineers and designers working together. The space, called Open Cell, will be opening its doors to the public this week for the London Design Festival. Chip boards made using potato waste, construction materials made with fungi and crystals […] September 16, 2018 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 14 Sep 2018 Novozymes Releases Enzyme That Helps Chickens Better Absorb Food Novozymes has released a new enzyme that breaks down bacterial cell debris in the gut and allows chickens to absorb more nutrients from their food. The Danish industrial biotech giant partnered with the Dutch health and nutrition company DSM to produce the bacterial muramidase enzyme solution, which is called ‘Balancius’. It has an interesting story […] September 14, 2018 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 14 Sep 2018 Cell Therapy Helps Regenerate Difficult Bone Fractures All patients in a clinical trial run by the Belgian company Bone Therapeutics have seen an improvement in the healing of bone fractures that have had problems healing. Six months after receiving a single dose of the cell therapy developed by Bone Therapeutics, all 21 patients in the Phase I/IIa clinical trial met the primary […] September 14, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 13 Sep 2018 Boehringer Ingelheim Acquires Oncolytic Virus Biotech Company Boehringer Ingelheim is paying €210M to acquire all the remaining shares of ViraTherapeutics, an Austrian biotech company developing oncolytic viral therapies for cancer. ViraTherapeutics develops cancer therapies based on viruses that selectively kill tumor cells, based on the principle that cancer cells show defective mechanisms to defend themselves against viruses that are not able to […] September 13, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 12 Sep 2018 Airbus Will Use Recombinant Spider Silk to Build Lightweight Planes Airbus has signed a partnership with German biotech AMSilk for the development of a new biomaterial to be used in the construction of future high-performance planes. Spider silk is known for having outstanding strength and flexibility. AMSilk uses engineered bacteria to produce spider silk protein, which is then used to create materials with a wide […] September 12, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email